Barclays PLC Celularity Inc Transaction History

Barclays PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$0.56 - $1.15 $8,564 - $17,586	15,293 Added 89.72%	32,338 $20,000
Q4 2022 Feb 13, 2023	BUY	$1.08 - $2.35 $15,324 - $33,344	14,189 Added 496.81%	17,045 $22,000
Q3 2022 Nov 03, 2022	BUY	$0.43 - $4.31 $891 - $8,938	2,074 Added 265.22%	2,856 $7,000
Q2 2022 Aug 12, 2022	BUY	$2.81 - $12.91 $2,197 - $10,095	782 New	782 $3,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.